VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
TYRA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
TYRATyra Biosciences, Inc.
$31.94$1.9B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksTYRAQuarterly Financials

Tyra Biosciences, Inc. (TYRA) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Tyra Biosciences, Inc. (TYRA) quarterly income statement — complete revenue, gross profit & net income history

TYRA Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold138K000000126K122K00000000000
COGS % of Revenue--------------------
Gross Profit-138K000000-126K-122K00000000000
Gross Margin %--------------------
Gross Profit Growth %---100%100%---------------
Operating Expenses41.86M36.52M32.94M31.45M31.85M29.74M28.6M23.41M22.2M25.63M23.96M16.01M14.33M15.02M13.64M15.43M14.83M9.93M6.64M5.51M
OpEx % of Revenue--------------------
Selling, General & Admin8.53M8.33M7.47M7.14M6.89M7.56M5.91M5.54M5.12M4.96M4.69M3.85M3.93M4.62M2.73M3.38M5.19M2.68M1.15M1.13M
SG&A % of Revenue--------------------
Research & Development33.33M28.19M25.47M24.31M24.96M22.18M22.7M17.87M17.08M20.68M19.27M12.16M10.41M10.4M10.91M12.05M9.64M7.25M5.48M4.38M
R&D % of Revenue--------------------
Other Operating Expenses00000000000000000000
Operating Income-42M-36.52M-32.94M-31.45M-31.85M-29.74M-28.6M-23.53M-22.32M-25.63M-23.96M-16.01M-14.33M-15.02M-13.64M-15.43M-14.83M-9.93M-6.64M-5.51M
Operating Margin %--------------------
Operating Income Growth %-31.86%-22.77%-15.17%-33.66%-42.68%-16.03%-19.37%-46.95%-55.73%-70.69%-75.62%-3.8%3.37%-51.21%-105.56%-180.1%-252.27%-170.11%--
EBITDA-41.86M-36.38M-32.81M-31.31M-31.71M-29.6M-28.48M-23.41M-22.2M-25.53M-23.88M-15.93M-14.25M-14.94M-13.56M-15.36M-14.77M-9.88M-6.6M-5.48M
EBITDA Margin %--------------------
EBITDA Growth %-32.02%-22.92%-15.23%-33.78%-42.82%-15.93%-19.25%-46.98%-55.78%-70.94%-76.07%-3.68%3.51%-51.14%-105.59%-180.24%-252.59%-170.15%--
D&A (Non-Cash Add-back)138K132K131K140K143K144K127K126K122K102K83K89K83K82K82K68K64K50K41K27K
EBIT-42M-36.52M-29.87M-31.45M-31.85M-29.74M-28.6M-23.53M-22.32M-25.63M-23.96M-16.01M-14.33M-15.02M-13.64M-15.43M-14.83M-9.93M-6.64M-5.51M
Net Interest Income2.69M2.68M03.35M3.7M4.17M4.59M4.83M4.13M2.81M2.81M2.74M2.45M2.16M1.13M346K18K5K2K4K
Interest Income2.69M2.68M03.35M3.7M4.17M4.59M4.83M4.13M2.81M2.82M2.76M2.45M2.16M1.13M346K18K5K2K4K
Interest Expense00000000005K21K00000000
Other Income/Expense2.69M2.68M3.08M3.35M3.7M4.17M4.59M4.83M4.13M2.8M2.81M2.74M2.45M2.12M1.14M333K8K2K-5K-4K
Pretax Income-39.3M-33.83M-29.87M-28.1M-28.15M-25.57M-24.02M-18.7M-18.19M-22.83M-21.15M-13.27M-11.88M-12.89M-12.51M-15.1M-14.83M-9.93M-6.64M-5.51M
Pretax Margin %--------------------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-39.3M-33.83M-29.87M-28.1M-28.15M-25.57M-24.02M-18.7M-18.19M-22.83M-21.15M-13.27M-11.88M-12.89M-12.51M-15.1M-14.83M-9.93M-6.64M-5.51M
Net Margin %--------------------
Net Income Growth %-39.64%-32.31%-24.37%-50.24%-54.72%-12.01%-13.54%-40.91%-53.13%-77.05%-69.09%12.08%19.87%-29.86%-88.3%-173.86%-252.25%-169.47%--
Net Income (Continuing)-39.3M-33.83M-29.87M-28.1M-28.15M-25.57M-24.02M-18.7M-18.19M-22.83M-21.15M-13.27M-11.88M-12.89M-12.51M-15.1M-14.83M-9.93M-6.64M-5.51M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.64-0.57-0.50-0.47-0.47-0.43-0.41-0.32-0.35-0.53-0.49-0.31-0.280.46-0.27-0.35-0.36-0.24-0.72-0.15
EPS Growth %-36.17%-32.56%-21.95%-46.88%-34.29%18.87%16.33%-3.23%-25%-215.22%-81.48%11.43%22.22%291.67%62.5%-133.33%-89.47%-50%--
EPS (Basic)-0.64-0.57-0.50-0.47-0.47-0.43-0.41-0.32-0.35-0.53-0.49-0.31-0.280.46-0.27-0.35-0.36-0.24-0.72-0.15
Diluted Shares Outstanding61.75M59.6M59.67M59.55M59.34M58.87M58.87M58.67M52.23M42.97M42.87M42.59M42.39M42.21M42M41.78M41.55M41.3M9.16M36.82M
Basic Shares Outstanding61.75M59.6M59.67M59.55M59.34M58.87M58.87M58.67M52.23M42.97M42.87M42.59M42.39M42.21M42M41.78M41.55M41.3M9.16M36.82M
Dividend Payout Ratio--------------------